Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)

SHA:600161 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	41,228	40,536	50,983	39,103	39,767	52,310
Market Cap Growth	-9.97%	-20.49%	30.38%	-1.67%	-23.98%	79.10%
Enterprise Value	41,991	38,978	49,023	37,846	37,744	52,384
Last Close Price	20.85	20.50	25.65	19.64	19.89	28.56
PE Ratio	28.24	26.17	45.94	44.39	52.33	81.86
Forward PE	24.36	29.48	39.63	39.14	45.04	67.68
PS Ratio	6.73	6.72	9.84	9.18	9.67	15.18
PB Ratio	2.84	2.79	4.00	3.44	3.87	8.67
P/TBV Ratio	4.27	4.20	5.69	4.78	5.27	12.60
P/FCF Ratio	-	-	38.74	-	-	561.25
P/OCF Ratio	-	49.45	21.30	34.73	40.56	74.51
PEG Ratio	-	52.10	52.10	52.10	52.10	52.10
EV/Sales Ratio	6.85	6.46	9.46	8.88	9.18	15.20
EV/EBITDA Ratio	15.55	14.04	25.08	26.07	28.75	44.33
EV/EBIT Ratio	17.78	15.77	28.73	29.27	32.15	49.94
EV/FCF Ratio	-	-	37.25	-	-	562.04
Debt / Equity Ratio	0.00	0.00	0.00	0.04	0.05	0.13
Debt / EBITDA Ratio	0.02	0.02	0.02	0.27	0.38	0.68
Debt / FCF Ratio	-	-	0.03	-	-	8.59
Asset Turnover	-	0.40	0.38	0.35	0.43	0.50
Inventory Turnover	-	0.82	0.99	0.97	1.00	0.85
Quick Ratio	-	3.41	3.66	4.25	6.65	2.62
Current Ratio	-	6.89	5.92	6.28	9.32	4.96
Return on Equity (ROE)	-	15.48%	12.52%	11.14%	13.12%	16.83%
Return on Assets (ROA)	-	10.28%	7.87%	6.59%	7.68%	9.46%
Return on Capital (ROIC)	10.61%	11.28%	8.69%	7.17%	8.33%	10.56%
Return on Capital Employed (ROCE)	-	16.80%	13.20%	11.00%	10.90%	15.90%
Earnings Yield	3.58%	3.82%	2.18%	2.25%	1.91%	1.22%
FCF Yield	-	-0.61%	2.58%	-0.58%	-0.38%	0.18%
Dividend Yield	0.48%	0.49%	0.49%	0.21%	0.35%	0.24%
Payout Ratio	-	15.96%	8.47%	17.85%	21.56%	14.54%
Buyback Yield / Dilution	-0.15%	-0.21%	0.62%	-2.79%	-7.41%	-0.59%
Total Shareholder Return	0.33%	0.28%	1.11%	-2.58%	-7.06%	-0.35%

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.